PMC7227336_01
"Total body" densitometry
40842_2020_95_Fig1_HTML.jpg
PMC7227336_01_40842_2020_95_Fig1_HTML.jpg
Fig1
Impedancemetry showed 11.9% of body fat, and "Total body" densitometry demonstrated 7.8% of total fat (Fig. 1).
Genealogical tree
40842_2020_95_Fig2_HTML.jpg
PMC7227336_01_40842_2020_95_Fig2_HTML.jpg
Fig2
(Fig. 2): a consanguineous marriage of grandparents (cousins) from the father's side, type 2 diabetes (father and grandmother from the father's side), breast cancer (father's sister), acute myocardial infarction (2 father's brothers), arterial hypertension (2 father's brothers), bicornuate uterus and endometriosis (sister), Crohn's disease (cousin from the father's side), arterial hypertension and obesity (mother), death in early childhood from the unknown reason (mother's brother and sister).
Electropherogram of DNA sequence of the CAVIN1 gene showing a homozygous variant c.631G < T resulting in the p.E211X mutation (codon is underlined) in the patient
40842_2020_95_Fig3_HTML.jpg
PMC7227336_01_40842_2020_95_Fig3_HTML.jpg
Fig3
AKT2, CIDEC, LIPE, LMNB2, PIK3CA, PPP1R3A, POLD1, WRN, ZMPSTE24, BANF1) using a custom Ion Ampliseq panel and Personal Genome Machine (ThermoFisher Scientific, Waltham, MA, USA) semiconductor sequencer (Ion Torrent) was performed. A novel pathogenic homozygous variant c.631G < T: p.E211X was detected in the CAVIN1 gene (Fig. 3), confirming the diagnosis of CGL type 4.